-
June 18, 2013
As per Reuters, several pharmaceutical companies have shown an interest in acquiring ViroPharma given the company's ...
-
June 18, 2013
AstraZeneca entered into an agreement with NGM Biopharmaceuticals, Inc. to develop candidates for type II diabetes ...
-
June 17, 2013
Namenda XR is a once-daily extended-release version of the company's immediate release formulation of Namenda.
-
June 17, 2013
XOMA Corporation announced the initiation of a pilot study to evaluate the use of gevokizumab in acute inflammatory ...
-
June 13, 2013
UCB recently presented new data on its lupus candidate, epratuzumab, from an open-label extension study of the ...
-
June 13, 2013
The FDA's advisory panel will review Salix' supplemental new drug application for Relistor for opioid-induced ...
-
June 12, 2013
ViroPharma recently received "orphan drug designation" in the EU for its pipeline candidate, maribavir, ...
-
June 12, 2013
Shares of Questcor received a major boost when the company announced the acquisition of development and ...
-
June 11, 2013
AstraZeneca entered into a definitive agreement to purchase US based privately-held company, Pearl Therapeutics
-
June 10, 2013
Gentium S.p.A. announced that it is seeking a re-examination of the negative opinion issued on defibrotide by the ...
-
June 10, 2013
Novartis (NVS) recently released encouraging data on its pipeline candidate, LDK378, from a phase I study.
-
June 07, 2013
Novartis recently announced positive results on Afinitor, from a phase III trial, BOLERO-3 (Breast cancer trials of ...
-
June 07, 2013
BioLineRx recently announced that it has enrolled the first patient in a phase II study of BL-8040, for the ...
-
February 12, 2013
UCB (UCBJF) and Amgen Inc. (AMGN) recently announced their decision to discontinue a phase III program being ...
-
February 08, 2013
Avanir Pharmaceuticals, Inc. (AVNR) reported first quarter fiscal 2013 net loss per share of 9 cents, wider than the ...
-
February 06, 2013
ArQule, Inc. (ARQL) and partner Daiichi Sankyo recently announced that former has enrolled the first patient for the ...
-
February 06, 2013
Good news flowed in at UCB (UCBJF) from Europe when the European Union (EU) approved Vimpat (lacosamide) as a single ...
-
February 04, 2013
Valeant Pharmaceuticals International, Inc. (VRX) recently closed the acquisition of Russia-based Natur Produkt ...
-
January 31, 2013
Auxilium Pharmaceuticals, Inc. (AUXL) recently announced the initiation of a patent infringement lawsuit against ...
-
January 30, 2013
Anacor Pharmaceuticals, Inc. (ANAC) recently announced positive preliminary results on tavaborole (AN2690) from ...
-
January 30, 2013
ARIAD Pharmaceuticals, Inc. (ARIA) recently announced the closure of its previously announced public offering. ARIAD ...
-
January 29, 2013
Seattle Genetics, Inc. (SGEN) recently presented interim results from a phase I study which is evaluating ASG-5ME ...
-
January 23, 2013
Novo Nordisk (NVO) recently announced that it has received approval in the EU (covering all 27 states) for its ...
-
January 23, 2013
Novartis' (NVS) global eye care division, Alcon, recently received a positive opinion from the Committee for ...
-
January 23, 2013
Impax Laboratories, Inc. (IPXL) received a major setback recently with the US Food and Drug Administration (FDA) ...
-
January 18, 2013
Onyx Pharmaceuticals, Inc. (ONXX) recently announced its intention to raise funds through the issuance of 4.4 ...
-
January 07, 2013
Salix Pharmaceuticals, Ltd. (SLXP) recently said that the FDA has approved the company's anti-diarrhea drug for ...
-
November 30, 2012
This morning's trading has marked a bad day for the market so far. The Nasdaq has decreased 0.4%; the S&P 500 has ...
-
November 27, 2012
The market is currently down, with the Nasdaq declining 0.2%, the S&P 500 slipping 0.2% and the Dow down 0.3%. The ...
-
November 12, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted third quarter earnings of 95 cents per share, well above the Zacks ...
-
November 08, 2012
The market is having a bad day so far: the Nasdaq has slipped 0.5%; the S&P 500 is trading down 0.2%; and the Dow ...
-
November 08, 2012
This morning's trading has marked a bad day for the market so far. The Nasdaq has fallen 0.5%; the S&P 500 is down ...
-
November 07, 2012
Can Endo reestablish itself as a quality healthcare name?
-
November 01, 2012
Wall Street kicked off the first day of November with a bang, as a slew of positive economic reports put some ...
-
September 10, 2012
The US Food and Drug Administration (FDA) recently informed Salix Pharmaceuticals, Ltd. (SLXP) that it is still ...
-
August 21, 2012
We recently downgraded Salix Pharmaceuticals, Ltd. (SLXP) to Neutral from Outperform. Salix faced a setback in ...
-
August 13, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted second quarter earnings of 79 cents per share, well above the Zacks ...
-
July 30, 2012
The market is currently down, with the Nasdaq decreasing 0.2%, the S&P 500 down 0.1% and the Dow slipping 0.1%. The ...
-
July 30, 2012
The market is having a bad day so far. The Nasdaq has fallen 0.2%; the S&P 500 has declined 0.1%; and the Dow is ...
-
July 11, 2012
Theravance Inc. (THRX) recently announced positive top-line results on TD-1211 from a phase IIb study, 0084. TD-1211 ...
-
June 12, 2012
With its economy beginning to slow, China has begun to unveil some new stimulus measures to boost sagging growth.
-
May 29, 2012
These days, it's not hard to find sectors and industries that are being adversely impacted by the confluence of ...
-
May 11, 2012
As global growth has begun to slow, the prices for various commodities have dwindled as well. However, natural ...
-
May 08, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted first quarter earnings of 67 cents per share, well above the Zacks ...
-
May 07, 2012
Salix Pharmaceuticals, Ltd. (SLXP) is facing a delay where the approval of two of its pipeline candidates is ...
-
March 29, 2012
India represents much opportunity. However, until it gets its infrastructure in order, that potential will be muted.
-
March 21, 2012
Despite all of these uncertainties, investors still heavily focus on whether a company's new drug will be approved ...
-
February 06, 2012
The steel sector suffered in 2011, due to fears about the slowing global economy and lower Chinese demand. That ...
-
February 03, 2012
The commodities market had some of the best-performing ETFs of January.
-
January 31, 2012
India represents much opportunity. However, until it gets its infrastructure in order, that potential will be muted.
-
January 18, 2012
Salix is a great candidate for growth investors.
-
July 31, 2011
Exchange traded funds are great complements to or substitutes for mutual funds, but they are also effective vehicles ...
-
July 06, 2011
With pricing beginning to firm and long-term steel demand rising, now is the best time to add the sector to a portfolio.
-
June 07, 2011
India represents much opportunity. However, until it gets its infrastructure in order, that potential will be muted.
-
May 18, 2011
India represents much opportunity. However, until it gets its infrastructure in order, that potential will be muted.
-
March 31, 2011
Valeant offers a rare win-win bid for Cephalon.
-
March 03, 2011
Salix has taken another blow from the FDA, but seems too cheap given its prospects.
-
February 25, 2011
These ETFs may have been a bit of a joke when they made their debut, but now these quirky funds are getting the last ...
-
October 27, 2010
As America searches for energy independence, natural gas consumption will increase.
-
October 25, 2010
Recent price drops present long-term opportunities, while many stable ETFs remain attractive. Learn your best ...
-
September 21, 2010
The Chinese government has started major spending to deal with mega traffic jams, and investors can get in on the ...
-
September 13, 2010
The president's current $50 billion plan to reinforce America's crumbling infrastructure could be a step in the ...
-
July 05, 2010
We look at the winners and losers resulting from a stronger yuan.
-
June 22, 2010
Sunoco announced the upcoming separation of its Sun Coke Energy business from the rest of the company.
-
May 19, 2010
With the falling euro, and oil and steel industries, some ETFs have been beaten down and are looking for a comeback.
-
April 05, 2010
A rising tide lifts all boats, and the same has held true in the ETF world with strong performances by the equity ...
-
March 24, 2010
While low prices are keeping a lid on producers, steel may be a stealth play on the growing natural gas industry.
-
February 26, 2010
Find out why you should take a fresh look at this age-old commodity.
-
December 23, 2009
A rebound in commodity prices served as the common theme among the best-performing ETFs this year.
-
June 08, 2009
Take a look at four Russian stocks that have been showing big gains and some high dividends.
-
May 05, 2009
Steel looks like it might be in teh process of turning around. Recent indicators show a shining future.
-
January 12, 2009
Will a "green revolution" be the ticket to 2009's hottest stocks? Only time will tell, but you can get in early by ...
-
December 09, 2008
Learn why two high-profile mergers were called off in the commodities sector and if there is still the potential for ...
-
June 30, 2008
Adding non-correlated assets shields a portfolio from volatility. We examine several exchange-traded funds that can ...
-
June 28, 2007
One steel ETF is blowing the doors off the S&P 500, while offering global diversify.
